Mostrar el registro sencillo del ítem
Analysis of Immunotherapy in Triple negative breast cancer
| dc.contributor.author | Burgos-Molina, Antonio Manuel | |
| dc.contributor.author | Alamilla Presuel, Juan Carlos | |
| dc.contributor.author | González Vidal, Alejandro | |
| dc.contributor.author | Ruiz-Gómez, Miguel José | |
| dc.date.accessioned | 2023-01-11T12:51:57Z | |
| dc.date.available | 2023-01-11T12:51:57Z | |
| dc.date.created | 2023 | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | https://hdl.handle.net/10630/25716 | |
| dc.description.abstract | TNBC cancer is complicated, most is about PD-L1 mechanism. Too many kinds of immunotherapy have been developed to treat TNCB. Nowadays, is complicated a fast and 100% accurate treatment for TNBC, because of cancer complications like metastasis. Nevertheless, metastasis is still being researched to prevent it and assure a better immunotherapy. Also, the immunotherapies must be improved too. | es_ES |
| dc.description.sponsorship | Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Aseica | es_ES |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.subject | Inmunoterapia - Congresos | es_ES |
| dc.subject | Cancer - Congresos | es_ES |
| dc.subject.other | Immunotherapy | es_ES |
| dc.subject.other | Triple negative breast | es_ES |
| dc.title | Analysis of Immunotherapy in Triple negative breast cancer | es_ES |
| dc.type | journal article | es_ES |
| dc.centro | Facultad de Medicina | es_ES |
| dc.relation.eventtitle | 18th ASEICA INTERNATIONAL CONGRESS | es_ES |
| dc.relation.eventplace | Santiago de Compostela, España. | es_ES |
| dc.relation.eventdate | 16 al 18 de Noviembre 2022 | es_ES |
| dc.departamento | Especialidades Quirúrgicas, Bioquímica e Inmunología | |
| dc.rights.accessRights | open access | es_ES |